Patent · US Active

Casein kinase 1 delta inhibitor

US10815230B2 · kind B2 · utility

2Cited by

0References

17Claims

0Family size

Assignee

ELECTROPHORETICS LIMITED · GB

Inventors

Ian Hugo Pike · London, GB
Karsten Kuhn · Dortmund, DE
Stefan Kienle · Frankfurt, DE
William D.O. Hamilton · Royston, GB
Jonathan R. Heal · Nottingham, GB
Joseph M. Sheridan · Royston, GB

Key dates

Filing date	May 13, 2016
Grant date	Oct 27, 2020
Priority date	—
Expiry date	May 13, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides 2-Methyl-amino-3-[(4-fluorophenyl)carbonyl]indolizine-1-carboxamide of formula (I) or a pharmaceutically acceptable salt thereof; and its therapeutic uses in the treatment of neurodegenerative disorders, in particular tauopathies and most preferably in the treatment of Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.